$DT

Enterprise software stocks surged after strong earnings reports and AI-driven growth. Salesforce, CrowdStrike, and Okta showed AI boosted their products. Appian (APPN) +8%, Atlassian (TEAM) +9.1%, Bandwidth (BAND) +10.1%, C3.ai (AI) +7%, Dynatrace (DT) +4.3%. Bandwidth is up 265% YTD but still below 52-week high.

Dynatrace, Inc. (DT) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Item 5.07. Submission of Matters to a Vote of Security Holders. On August 26, 2026, Dynatrace, Inc. (the "Company") held its annual meeting of stockholders (the "Annual Meeting") to consider and vote on the three proposals set forth below, each of which is described in greater de

Dynatrace (DT) released research showing SRE and platform engineering teams are critical for AI scalability and reliability in enterprises. The study found 92% of organizations support SRE initiatives, and 89% of platform engineering teams have implemented internal developer platforms. Dynatrace plans to acquire Arize to integrate AI-native evaluation into its observability platform, addressing the growing demand for AI model monitoring and tool integration challenges.

Morgan Stanley upgraded Dynatrace Inc to Overweight, raising its price target to $65 from $58. The firm cited strong demand for observability software, AI capabilities, and a large customer renewal cycle. Morgan Stanley expects Dynatrace's net-new annual recurring revenue growth to exceed 20% in fiscal 2027-2029, with a key catalyst being a 50% larger renewal cohort. The brokerage noted Dynatrace's expansion into AI observability and autonomous operations, including its acquisition of Arize. Acc

Dick's Sporting Goods (DKS) fell 27% after reporting $5.59B in sales, missing estimates. Dynatrace (DT) rose 3% on a Morgan Stanley upgrade. Shift4 Payments (FOUR) gained 4% after a Wells Fargo upgrade. Moderna (MRNA) climbed 13% following a Wolfe Research upgrade. Marvell (MRVL) jumped 5% on higher price targets. AMD (AMD) rose 5% after a Raymond James upgrade. Kura Oncology (KURA) gained 10% after CEO bought shares. Navitas Semiconductor (NVTS) rose 5% on a $232.8M deal with Claros.

Morgan Stanley upgraded Dynatrace (DT) to overweight, raising its price target to $65 from $58, citing strong demand in the observability market. The bank expects 20%+ growth and margin expansion for DT, driven by AI and cloud growth. DT shares are up 13% YTD, with 26 of 37 analysts recommending buy or strong buy.

Analysts made several calls on Tuesday. JPMorgan raised Dell's price target to $565, citing expected revenue growth. Wolfe upgraded Moderna to peer perform, noting its focus on therapeutics. UBS upgraded Fluence to neutral, seeing an earnings trough. Morgan Stanley upgraded Dynatrace to overweight, forecasting growth. Goldman initiated Jersey Mike's as neutral, citing full valuation. Wolfe upgraded Netflix to outperform, raising its price target to $95. Bank of America reiterated Nvidia, Micron,

Analysts upgraded five companies: UBS raised Fluence Energy's (FLNC) target to $12, Morgan Stanley boosted Dynatrace's (DT) target to $65, Raymond James upgraded AMD (AMD) to Strong Buy with a $641 target, Bernstein increased Summit Therapeutics' (SMMT) target to $11.9, and Wells Fargo raised Shift4 Payments' (FOUR) target to $59.

Dynatrace research shows 92% of organizations support SRE teams for AI reliability. AI workloads are increasingly in production, raising demands for observability. Dynatrace plans to acquire Arize to integrate AI-native evaluation into its platform. Gartner projects significant AI growth by 2028. According to the study, 89% of SREs use SLOs, and 67% prioritize monitoring AI models. Platform engineers focus on AI-powered developer tools.

Dynatrace (DT) stock rose 2.7% in pre-market trading after Morgan Stanley upgraded it to Overweight with a $65 price target, citing expected net-new ARR growth recovery. Other analysts, including Baird and Goldman Sachs, also raised their price targets. The company's pending acquisition of Arize for $915 million was noted as a potential catalyst. The broader market showed gains, with the Nasdaq up 0.9%.